Metropolitan Life Insurance Company (MetLife)’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,613
| Closed | -$10.6K | – | 217 |
|
|
2024
Q1 | $10.6K | Buy |
2,613
+416
| +19% | +$1.68K | ﹤0.01% | 2120 |
|
|
2023
Q4 | $6.7K | Sell |
2,197
-2,381
| -52% | -$7.26K | ﹤0.01% | 2267 |
|
|
2023
Q3 | $13.7K | Hold |
4,578
| – | – | ﹤0.01% | 2071 |
|
|
2023
Q2 | $17.1K | Buy |
+4,578
| New | +$17.1K | ﹤0.01% | 2014 |
|
|
2023
Q1 | – | Sell |
-4,928
| Closed | -$23.7K | – | 2325 |
|
|
2022
Q4 | $23.7K | Hold |
4,928
| – | – | ﹤0.01% | 1920 |
|
|
2022
Q3 | $28K | Hold |
4,928
| – | – | ﹤0.01% | 1830 |
|
|
2022
Q2 | $35K | Hold |
4,928
| – | – | ﹤0.01% | 1719 |
|
|
2022
Q1 | $35.6K | Sell |
4,928
-13,943
| -74% | -$101K | ﹤0.01% | 1783 |
|
|
2021
Q4 | $169K | Hold |
18,871
| – | – | ﹤0.01% | 2143 |
|
|
2021
Q3 | $662K | Buy |
+18,871
| New | +$662K | 0.01% | 1261 |
|
|
2021
Q2 | – | Sell |
-4,621
| Closed | -$285K | – | 2725 |
|
|
2021
Q1 | $285K | Sell |
4,621
-226
| -5% | -$14K | ﹤0.01% | 1777 |
|
|
2020
Q4 | $203K | Buy |
+4,847
| New | +$203K | ﹤0.01% | 1928 |
|